VRTX and AMGN Related Headlines
Go Back- Jefferies Starts Amgen (AMGN) at Hold
- Jefferies Starts Vertex (VRTX) at Buy
- Jefferies Starts Gilead Sciences (GILD) at Buy
- Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
- FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'
- U.S. large biotech stocks Q2 earnings preview
